& Ahmadiani, A
Some may opt for injections due to familiarity or because it suits their lifestyle better, while others may find the oral option to be a hassle-free alternative
Para saber ms World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
If you are comfortable with compounded medication from a licensed pharmacy, go for Peak which offers the same thing for less
Find out if you qualify for GLP-1 treatment and connect with trusted providers no in-person visit required
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone